AMGN logo

Amgen
AMGN

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
$186.02B
EV
$231.17B
Shares Outstanding
540.52M
Beta
0.45
Industry
Drug Manufacturers - General

Wall Street View

Analyst Rating
OUTPERFORM
Analyst Target Price
Number of Analysts
27
P/E 2025E
16.26x
P/Revenue 2025E
5.12x

Historical 3Y Growth Rate

Revenue
EPS
Operating Cash Flow
Free Cash Flow

Forecasted 3Y Growth Rate

Revenue
EPS
Operating Cash Flow
Free Cash Flow

Margins & Returns

Gross Margin 2025E
82.72%
Net Profit Margin 2025E
20.22%
ROE 2025E
161.30%
ROCE 2024
67.55%

Dividends

DPS 2025E
$9.56
Payout Ratio 2025E
45.01%
Div. Yield 2025E
2.81%
DPS Last 3Y CAGR

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Amgen Inc.

gainify
AMGN logo

Amgen Inc.

AMGN

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. The company’s principal products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Otezla for the treatment of adult patients with plaque ps...

Sector

Healthcare

Industry

Drug Manufacturers - General

CEO

Bradway, Robert

Employees

28,000

IPO Date

1983-06-17

Headquarters

One Amgen Center Drive, Thousand Oaks, California, 91320-1799, United States

gainifypowered-by-sp
Socials
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on ThreadsCheck us out on TrustpilotFollow us on YouTubeFind us on Google Maps

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2025 Gainify. All rights reserved.